B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Punch immunotherapy trial aims to tame resistant blood cancer
Disease control OngoingThis study is testing a combination of two advanced immunotherapies for people with B-cell Non-Hodgkin lymphoma that has come back or not responded to standard treatments. The goal is to see if using a bispecific antibody drug together with engineered immune cells (CAR-T cells) i…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Double-Punch combo trial aims to boost Cancer-Killing power
Disease control OngoingThis study is testing whether adding a pill called acalabrutinib makes a powerful cell therapy (CAR-T) work better and safer for people with certain aggressive B-cell lymphomas. The trial enrolled 23 adults to see if the combination is safe and can help control the cancer. Resear…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Simple blood test could replace scans for cancer monitoring
Diagnosis OngoingThis study is testing whether a blood test can detect if aggressive B-cell lymphoma has returned after chemotherapy treatment. Researchers are following 501 patients to see if this test can identify cancer recurrence earlier than standard scans and exams. The goal is to determine…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC
-
Simple blood test could predict lymphoma treatment success
Knowledge-focused OngoingThis study is testing whether tracking lymphoma DNA in blood can help predict how well treatment is working. Researchers will collect blood samples from 60 lymphoma patients before, during, and after treatment to see if changes in this DNA match up with scan results and long-term…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC